RecallClass 2 · Action within 48 hours
Class 2 Medicines Recall: Hameln Pharma Ltd, Clarithromycin 500 mg powder for concentrate for solution for infusion, EL(25)A/53
Read and act on the official notice on GOV.UK
Class 2 recall — Action within 48 hours.
The MHRA uses Class 2 when:
The defect may cause mistreatment or harm to the patient, but it is not life-threatening or serious.
What all four recall classes mean
| Class | Action | The MHRA's definition |
|---|---|---|
| Class 1 | Immediate action | The defect presents a risk of death or disability. |
| Class 2 this recall | Action within 48 hours | The defect may cause mistreatment or harm to the patient, but it is not life-threatening or serious. |
| Class 3 | Action within 5 days | The defect is unlikely to cause harm to the patient. |
| Class 4 | Caution in use | Usually minor defects in packaging or other printed materials. |
A Class 1 recall usually comes with a National Patient Safety Alert. Source: MHRA, safety communications.
The MHRA's summary
Hameln Pharma Ltd is recalling certain batches of Clarithromycin 500 mg powder for concentrate for solution for infusion.
Affected batches
As listed by the MHRA, exactly as published. Always check against the GOV.UK notice before acting.
| Batch number | Expiry | Pack size | First distributed |
|---|---|---|---|
| Clarithromycin 500 mg powder for concentrate for solution for infusion | |||
| 23J097 | 30/09/2027 | 10 | 07/11/2023 |
| 23J098 | 30/09/2027 | 10 | 11/12/2023 |
| 23J099 | 30/09/2027 | 10 | 08/01/2024 |
| 23J100 | 30/09/2027 | 10 | 09/02/2024 |
| 24A227 | 30/11/2027 | 10 | 10/05/2024 |
| 24A230 | 31/12/2027 | 10 | 12/08/2024 |
| 24E038 | 31/01/2028 | 10 | 22/08/2024 |
| 24E039 | 29/02/2028 | 10 | 17/09/2024 |
| 24E040 | 29/02/2028 | 10 | 03/10/2024 |
| 24G130 | 30/04/2028 | 10 | 11/11/2024 |
| 24G330 | 30/04/2028 | 10 | 28/11/2024 |
| 24G331 | 30/04/2028 | 10 | 03/12/2024 |
| 24G333 | 30/06/2028 | 10 | 30/12/2024 |
| 24I243 | 31/07/2028 | 10 | 07/01/2025 |
| 24I245 | 31/07/2028 | 10 | 20/01/2025 |
| 24I400 | 31/07/2028 | 10 | 03/02/2025 |
| 24I402 | 30/09/2028 | 10 | 12/02/2025 |
| 24I403 | 30/09/2028 | 10 | 04/03/2025 |
| 24I404 | 30/09/2028 | 10 | 25/03/2025 |
| 24I418 | 30/09/2028 | 10 | 14/04/2025 |
| 24K161 | 31/10/2028 | 10 | 28/04/2025 |
| 24K162 | 31/10/2028 | 10 | 16/05/2025 |
| 24K163 | 31/10/2028 | 10 | 27/05/2025 |
| 24K164 | 30/11/2028 | 10 | 27/05/2025 |
| 24K165 | 30/11/2028 | 10 | 16/06/2025 |
| 24K166 | 30/11/2028 | 10 | 08/07/2025 |
| 24K167 | 30/11/2028 | 10 | 04/08/2025 |
| 24K168 | 30/09/2028 | 10 | 24/04/2025 |
| 25D674 | 31/03/2029 | 10 | 26/08/2025 |
| 25D675 | 31/03/2029 | 10 | 19/09/2025 |
| 25F174 | 31/05/2030 | 10 | 09/10/2025 |
| 25F175 | 31/05/2030 | 10 | 31/10/2025 |
| 25F263 | 31/05/2030 | 10 | 19/11/2025 |
MHRA's audience tags: Dispensing GP practices, Pharmacy